Pain Assessment and Multimodal Analgesia Principles

Why Pain Assessment Matters in Veterinary Technology

Animals cannot report pain verbally, so the veterinary technician's ability to recognize and quantify pain is essential for patient welfare. Unmanaged pain delays healing, suppresses immune function, and causes unnecessary suffering. Regulatory bodies and professional standards increasingly require documented pain assessments as part of the medical record. As a credentialed veterinary technician, you are expected to perform pain assessments, communicate findings to the supervising veterinarian, and monitor patients receiving analgesic therapy — all within your state-defined scope of practice.

Validated Pain Scoring Tools

Two widely accepted tools are used in small animal practice for acute pain assessment.

Colorado State University (CSU) Canine Acute Pain Scale uses a 0–4 numeric scale combining behavioral observations (posture, facial expression, response to palpation, vocalization, and activity level) with physiologic cues. A score of 0 represents no detectable pain; a score of 4 represents severe pain with the animal unresponsive to environment or extremely reactive. A score of 2 or higher generally prompts re-evaluation and consideration of analgesic intervention. A companion feline version exists and follows a similar structure.

Glasgow Composite Measure Pain Scale — Short Form (CMPS-SF) was developed and validated for dogs experiencing acute pain. It assesses six behavioral categories — vocalization, attention to wound, mobility, response to touch, demeanor, and posture/activity — yielding a maximum score of 24. An intervention threshold of 6 out of 24 is recommended by the tool's developers. The short form takes approximately two minutes to complete and is well suited to busy clinical environments.

Both tools require consistent technique: observe the patient undisturbed first, then approach and palpate. Always document the score, the time, the assessor's name, and any interventions in the medical record.

Safety point: Pain scores are clinical findings that must be communicated promptly to the supervising veterinarian. The technician does not independently decide to administer controlled substances; the veterinarian orders analgesics. However, early and accurate reporting is a direct patient safety function.

The Four Phases of the Pain Pathway

Understanding the pain pathway explains why multimodal analgesia — using more than one drug class simultaneously — is more effective than single-agent therapy.

Transduction is the conversion of a noxious stimulus (tissue injury, heat, pressure) into an electrical signal at peripheral nociceptors. Prostaglandins, bradykinin, and substance P sensitize nociceptors at this site. NSAIDs (non-steroidal anti-inflammatory drugs) act here by inhibiting cyclooxygenase enzymes and reducing prostaglandin synthesis. Local anesthetics applied peripherally (e.g., wound infiltration) also block signal initiation at this phase.

Transmission is the conduction of the electrical signal along peripheral nerve fibers (A-delta and C fibers) to the spinal cord dorsal horn. Local anesthetics — such as lidocaine or bupivacaine used in regional nerve blocks — interrupt this conduction and are the primary drug class targeting transmission.

Modulation occurs in the spinal cord dorsal horn, where the signal can be amplified or dampened. Wind-up and central sensitization, which result in exaggerated and prolonged pain responses, occur here. Opioids bind mu, kappa, and delta receptors in the dorsal horn to inhibit signal progression. Alpha-2 adrenergic agonists (e.g., dexmedetomidine) act at spinal and supraspinal sites to reduce signal transmission. NMDA (N-methyl-D-aspartate) antagonists such as ketamine block NMDA receptors that drive wind-up, preventing central sensitization at sub-anesthetic doses.

Perception is the conscious recognition of pain, processed in the brain's somatosensory cortex, limbic system, and thalamus. Opioids and alpha-2 agonists also act supraspinally at this phase, altering how the brain interprets nociceptive input. General anesthetics suppress perception during surgical procedures.

The Multimodal Analgesia Concept

Multimodal analgesia means combining drugs from different classes that act on different parts of the pain pathway. This approach achieves better pain control at lower doses of each individual drug, thereby reducing dose-dependent side effects. A typical perioperative protocol might include a preoperative opioid (modulation and perception), an NSAID given intraoperatively or postoperatively (transduction), a regional nerve block using a local anesthetic (transmission), and low-dose ketamine as a constant-rate infusion (modulation). Each drug contributes at a distinct site, creating overlapping and synergistic analgesia.

Safety point: NSAIDs are contraindicated in patients with renal compromise, dehydration, coagulopathy, or concurrent corticosteroid use. Always verify the patient's hydration and renal status before preparing or administering NSAID therapy, and confirm the veterinarian's order and any contraindication review before drug administration. Alpha-2 agonists cause cardiovascular depression and must be used with caution in patients with cardiac disease. Ketamine is a controlled substance (Schedule III federally); follow all controlled substance record-keeping requirements.

Communicating with Clients

Discharge instructions must be delivered in plain language. Avoid jargon such as "multimodal" or "cyclooxygenase." Instead, explain what each medication is for, how often to give it, what to watch for, and when to call the clinic. For example: "This pain pill should be given once a day with food. If your dog stops eating, seems more painful, or vomits, call us right away. Do not give any over-the-counter human pain relievers — many are toxic to pets." Written instructions should reinforce verbal communication.